Clinical, neuropathologic and pharmacologic aspects of Huntington's disease: Correlates with a new animal model
- 1 January 1977
- journal article
- Published by Elsevier in Progress in Neuro-Psychopharmacology
- Vol. 1 (1-2) , 13-30
- https://doi.org/10.1016/0364-7722(77)90025-x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Loss of striatal serotonin synaptic receptor binding induced by kainic acid lesions: correlations with Huntington's Disease1Journal of Neurochemistry, 1977
- Neurochemical sequelae of kainate injections in corpus striatum and substantia nigra of the ratLife Sciences, 1977
- Huntington's Disease: Regional alteration in muscarinic cholinergic receptor binding in human brainLife Sciences, 1976
- Receptors for amino acids in excitable tissuesGeneral Pharmacology: The Vascular System, 1976
- ENZYMES ASSOCIATED WITH THE METABOLISM OF CATECHOLAMINES, ACETYLCHOLINE AND GABA IN HUMAN CONTROLS AND PATIENTS WITH PARKINSON'S DISEASE AND HUNTINGTON'S CHOREAJournal of Neurochemistry, 1976
- Electrophysiological evidence for involvement of cyclic adenosine monophosphate in dopamine responses of caudate neuronsLife Sciences, 1974
- DIMETHYL AMINOETHANOL IN HUNTINGTON'S CHOREAThe Lancet, 1973
- Excitation of mammalian central neurones by acidic amino acidsBrain Research, 1972
- Huntington’s Disease of Young PeopleEuropean Neurology, 1970
- Mutation in Huntington's chorea.Journal of Neurology, Neurosurgery & Psychiatry, 1969